Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|October 5, 2012
Swab protocol for rapid laboratory diagnosis of cutaneous anthraxLeslie A Dauphin, Chung K Marston, Vinod Bhullar, et al.
Neuroscience of Consciousness|October 12, 2020
Missing the forest because of the trees: slower alternations during binocular rivalry are associated with lower levels of visual detail during ongoing thoughtNerissa Siu Ping Ho, Daniel Baker, Theodoros Karapanagiotidis, et al.
Arthritis and Rheumatism|September 30, 2008
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitisDésirée van der Heijde, Robert Landewé, Xenofon Baraliakos, et al.
Bioanalysis|October 9, 2025
Patient centric blood sampling and analysis for diagnostics and laboratory medicineNeil Spooner, Daniel Baker, Rachel S Carling, et al.
Arthritis Research & Therapy|October 10, 2007
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseasesChenglong Han, Josef S Smolen, Arthur Kavanaugh, et al.
Annals of the Rheumatic Diseases|September 18, 2012
Golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeksTsutomu Takeuchi, Masayoshi Harigai, Yoshiya Tanaka, et al.
Annals of the Rheumatic Diseases|November 29, 2011
Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH studyYoshiya Tanaka, Masayoshi Harigai, Tsutomu Takeuchi, et al.
Modern Rheumatology|December 9, 2017
Clinical efficacy, radiographic, and safety results of golimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior therapy with disease-modifying antirheumatic drugs: Final results of the GO-MONO trial through week 120Tsutomu Takeuchi, Masayoshi Harigai, Yoshiya Tanaka, et al.
Arthritis and Rheumatism|September 2, 2008
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year periodJürgen Braun, Atul Deodhar, Ben Dijkmans, et al.
Annals of the Rheumatic Diseases|January 15, 2017
A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexateJosef S Smolen, Sandeep K Agarwal, Elena Ilivanova, et al.
Pageof 8